Houston Clinical Trials, LLC
Bellaire, Texas, United States
Research institute in Bellaire, Texas
6330 W Loop S, Bellaire, TX 77401
About Houston Clinical Trials, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Naurex, Inc, an affiliate of Allergan plc
4
Emalex Biosciences Inc.
2
Pfizer
2
Allergan
1
Jazz Pharmaceuticals
1
Clinical Trials at Houston Clinical Trials, LLC
During the past decade, Houston Clinical Trials, LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
2016-11-02
2018-11-21
Completed
429
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
2016-11-13
2019-02-22
Completed
1,304
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
2017-02-03
2018-12-06
Completed
617
Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric Patients (7-17 Years) With Major Depressive Disorder
2018-07-06
2021-03-01
Completed
501
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
2018-08-23
2019-07-03
Terminated
230
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
2019-06-20
2021-09-23
Completed
153
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension
2019-10-04
2022-11-11
Completed
124
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
2021-01-15
2031-07-15
Recruiting
2,100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Houston Clinical Trials, LLC" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 4 trials, followed by "Emalex Biosciences Inc." with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Jazz Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Houston Clinical Trials, LLC
According to Clinical.Site data, the most researched conditions in "Houston Clinical Trials, LLC" are
"Depressive Disorder, Major" (4 trials), "Acute Treatment of Migraine" (1 trials), "Major Depressive Disorder" (1 trials), "Pediatric Migraine" (1 trials) and "Post Traumatic Stress Disorder" (1 trials). Many other conditions were trialed in "Houston Clinical Trials, LLC" in a lesser frequency.
Clinical Trials Intervention Types at Houston Clinical Trials, LLC
Most popular intervention types in "Houston Clinical Trials, LLC" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Rapastinel" (4 trials), "Ecopipam" (2 trials), "Fluoxetine" (1 trials) and "JZP150" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Houston Clinical Trials, LLC
The vast majority of trials in "Houston Clinical Trials, LLC" are
10 trials for "All" genders.
Clinical Trials Status at Houston Clinical Trials, LLC
Currently, there are NaN active trials in "Houston Clinical Trials, LLC".
undefined are not yet recruiting,
3 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Houston Clinical Trials, LLC,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Houston Clinical Trials, LLC, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".